Physician

Germaine M Blaine, MD

According to 2025 Medicare claims, Germaine Blaine, MD (NPI: 1598727570) practices hospice and palliative care in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is HEALTH FIRST MEDICAL GROUP, LLC (NPI: 1750626495; TIN: 461243081) and primary practice location at 32901-1973. Blaine is affiliated with the Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Blaine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 562 traditional Medicare patients, billed 113,787 HCPCS/CPT codes, and received $1,763,237 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 553 prescription claims across 136 beneficiaries totaling $600,528 in drug costs, led by Brukinsa (Zanubrutinib). 2019 DME data shows 18 claims. Open Payments data shows 1 records totaling $75. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,149,757 and ending at $1,763,237. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $726,956 and ending at $600,528. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	409	102,825	$1,149,757
2016	94	200	$20,872
2017	798	135,580	$2,211,840
2018	961	233,063	$2,966,548
2019	860	180,469	$2,490,668
2020	25	60	$8,205
2021	N/R	N/R	N/R
2022	14	20	$2,174
2023	N/R	N/R	N/R
2024	562	113,787	$1,763,237

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	132	778	$726,956
2016	122	582	$23,014
2017	104	345	$275,431
2018	127	590	$1,413,183
2019	158	881	$1,950,908
2020	116	401	$194,302
2021	52	289	$16,121
2022	80	271	$26,951
2023	106	582	$93,814
2024	136	553	$600,528

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$605
2017	N/R	12	$330
2018	N/R	N/R	N/R
2019	N/R	18	$4,054
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	115	209	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	69	104	$95
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	85	143	$46
J0897	Injection, denosumab, 1 mg	84	6,900	$21
96372	Injection of drug or substance under skin or into muscle	158	284	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	12	360	$123,797
Lenalidomide	Lenalidomide	11	266	$78,997
Abiraterone Acetate	Abiraterone Acetate	11	230	$41,757
Eliquis	Apixaban	26	1,065	$19,837
Xarelto	Rivaroxaban	19	750	$13,848

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$75	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Germaine M. Blaine, MD?

Tedicare shows public-source Medicare data for Germaine M. Blaine, MD (NPI 1598727570), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Germaine M. Blaine, MD have ACO affiliation data?

Germaine M. Blaine, MD is shown with ACO affiliation data for Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Germaine M. Blaine, MD?

Germaine M. Blaine, MD is linked to HEALTH FIRST MEDICAL GROUP, LLC (billing NPI 1750626495) in the available physician profile data.

Does Germaine M. Blaine, MD have Open Payments data?

Germaine M. Blaine, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.